EyePoint Pharmaceuticals Inc logo

EyePoint Pharmaceuticals Inc

$ 7.39 -0.26 (-3.4%) 08:08 PM EST
P/E:
At Loss
P/B:
1.62
Market Cap:
$ 251.79M
Enterprise V:
$ 133.97M
Volume:
106.21K
Avg Vol (2M):
129.97K
Also Trade In:
Volume:
106.21K
Market Cap $:
251.79M
PE Ratio:
At Loss
Avg Vol (2-Month):
129.97K
Enterprise Value $:
133.97M
PB Ratio:
1.62
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 3.85
Equity-to-Asset 0.65
Debt-to-Equity 0.29
Debt-to-EBITDA -0.64
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.7
Distress
Grey
Safe
Beneish M-Score -2.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.23
9-Day RSI 36.27
14-Day RSI 34.87
6-1 Month Momentum % -18.52
12-1 Month Momentum % -0.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.17
Quick Ratio 6.07
Cash Ratio 5.13
Days Inventory 175.83
Days Sales Outstanding 157.14
Days Payable 294.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -65.7

Financials (Next Earnings Date:2022-11-03 Est.)

EYPT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EYPT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 41.462
EPS (TTM) ($) -2.25
Beta 1.11
Volatility % 66.66
14-Day RSI 34.87
14-Day ATR ($) 0.528112
20-Day SMA ($) 8.1825
12-1 Month Momentum % -0.29
52-Week Range ($) 6.91 - 21.5
Shares Outstanding (Mil) 34.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

EyePoint Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

EyePoint Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.